IBI129

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI129, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]